top of page
PUBLICATIONS
2020-2022
1. Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy Sudhindra Pete, Nilmadhab Roy, Binoy Kar, Priyankar Paira*
Coordination Chemistry Reviews, 2022, 460, 214462 https://doi.org/10.1016/j.ccr.2022.214462
​
​
2. 9-Arylacenaphtho[1,2-b]quinoxalines via Suzuki coupling reaction as cancer therapeutic and cellular imaging agents†
Lavanya Thilak Babu and Priyankar Paira *
New J. Chem., 2021,45, 20447-20458 https://doi.org/10.1039/D1NJ03915F
​
​
3. 2, 2′-Bipyrimidine-based luminescent Ru (ii)/Ir (iii)–arene monometallic and homo-and hetero-bimetallic complexes for therapy against MDA-MB-468 and caco-2 cells
Nilmadhab Roy, Utsav Sen, Prithvi Moharana, Lavanya Thilak Babu, Binoy Kar, Seshu Vardhan, Suban K Sahoo, Bipasha Bose, Priyankar Paira*
Dalton Trans., 2021,50, 11725-11729 https://doi.org/10.1039/D1DT01556G
​
​
4.GSH-resistant and highly cytoselective ruthenium (ii)-p-cymene-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol complexes as potential anticancer agents
Binoy Kar, Utpal Das, Sourav De, Sudhindra Pete, Ajay Sharma, Nilmadhab Roy, Ashok Kumar SK, Debashis Panda, Priyankar Paira*
Dalton Trans., 2021,50, 10369-10373 https://doi.org/10.1039/D1DT01604K
​
​
​
5 Iridium(III)-Cp*-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer and mitochondria targeting Cancer stem cell therapeutic agent‡
Binoy Kar, Apoorva H Nagendra, Utpal Das, Nilmadhab Roy, Sudhindra Pete, Ajay Sharma, Sourav De, Ashok SK Kumar, POTHABATHULA SESHU VARDHAN, Suban K Sahoo, Debashis Panda, Sudheer Shenoy, Bipasha Bose, Priyankar Paira*
Dalton Trans., 2022, https://doi.org/10.1039/D2DT00168C
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
bottom of page